January 6, 2021 – AmerisourceBergen Corporation and Walgreens Boots Alliance, Inc. announced strategic agreements under which AmerisourceBergen will acquire the majority of Walgreens Boots Alliance’s Alliance Healthcare businesses for approximately $6.5 billion, comprised of $6.275 billion in cash and 2 million shares of AmerisourceBergen common stock.
In a press release, the companies said the transaction would allow Walgreens Boots Alliance to increase its focus on expanding its core retail pharmacy businesses.
In addition to this transaction, the two companies have agreed to strengthen their strategic partnership by extending and expanding their commercial agreements.
Their US distribution agreement will be extended by three years until 2029 and their partnership is being expanded to include a commitment to pursue additional opportunities in sourcing and distribution.
Furthermore, Alliance Healthcare UK will remain the distribution partner of Boots until 2031.
These announcements between the two global enterprises continue to build on the close partnership that began in 2013. Walgreens Boots Alliance is the largest shareholder of AmerisourceBergen with a stake of nearly 30 percent, and Ornella Barra, Co-Chief Operating Officer, Walgreens Boots Alliance, is a Board Member of AmerisourceBergen.
The transaction is expected to close by AmerisourceBergen’s fiscal year-end 2021.